LEIDS UNIVERSITAIR MEDISCH CENTRUM - Netherlands 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 80
As coordinator: 14
As participant: 55
Sole participant: 11
Coordinator / Participant Ratio: 0.25*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 12.147.314 6.771.571 6.300.750 2 1
2022 6.606.932 44.575.558 8.233.163 4 7
2021 11.639.913 61.552.405 13.719.076 6 14
2020 9.656.548 302.464.789 13.851.591 5 19
2019 23.998.245 186.376.524 14.323.634 8 14

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE18
CHARITE UNIVERSITAETSMEDIZIN BERLIN12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM11
UNIVERSITY OF COPENHAGEN11
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE10
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V10
KATHOLIEKE UNIVERSITEIT LEUVEN10
PERCUROS BV9
THE UNIVERSITY OF EDINBURGH9
UNIVERSITY OF OSLO9
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK8
EUROPEAN MOLECULAR BIOLOGY LABORATORY8
KAROLINSKA INSTITUTE8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
UNIVERSITY OF CAMBRIDGE8
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG7
JANSSEN PHARMACEUTICA NV7
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT7
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV7
THE UNIVERSITY OF MANCHESTER7
UNIVERSITAT DE BARCELONA7
UNIVERSITY COLLEGE LONDON7
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG6
COMMISSARIAT A L'ENERGIE ATOMIQUE6
EATRIS ERIC6
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT6
HEINRICHHEINEUNIVERSITAET DUESSELDORF6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE6
ISTITUTO SUPERIORE DI SANITA6
KING'S COLLEGE LONDON6
OSLO UNIVERSITETSSYKEHUS HF6
PFIZER LIMITED6
SANOFIAVENTIS6
THE UNIVERSITY OF TUEBINGEN6
UNIVERSITAETSKLINIKUM FREIBURG6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
UNIVERSITEIT UTRECHT6
UNIVERSITY OF DUNDEE6
UNIVERSITY OF HELSINKI6
ACADEMISCH ZIEKENHUIS GRONINGEN5
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
DANMARKS TEKNISKE UNIVERSITET5
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT5
MASARYKOVA UNIVERZITA5
MEDIZINISCHE UNIVERSITAET WIEN5
MEDIZINISCHE UNIVERSITAT INNSBRUCK5
NOVARTIS PHARMA5
SORBONNE UNIVERSITE5
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM5
STICHTING RADBOUD UNIVERSITEIT5
TECHNISCHE UNIVERSITAET MUENCHEN5
UNIVERSIDAD DE GRANADA5
UNIVERSITA DEGLI STUDI DI CAMERINO5
UNIVERSITAET ZUERICH5
UNIVERSITAETSKLINIKUM AACHEN5
UNIVERSITE D'AIX MARSEILLE5
UNIVERSITEIT ANTWERPEN5
UNIVERSITEIT MAASTRICHT5
UNIVERSITY OF AARHUS5
UNIVERSITY OF WALES CARDIFF5
ABBVIE INC4
ACADEMIC MEDICAL CENTRE AMSTERDAM4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
ASTRAZENECA4
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM4
CENTRE DE REGULACIO GENOMICA4
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS4
CONSIGLIO NAZIONALE DELLE RICERCHE4
DRESDEN UNIVERSITY OF TECHNOLOGY4
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA4
GOETEBORGS UNIVERSITET4
INSTITUT PASTEUR4
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES4
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW4
LUND UNIVERSITY4
MEDIZINISCHE UNIVERSITAT GRAZ4
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU4
SERVICIO MADRILENO DE SALUD4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
TAKEDA PHARMACEUTICALS INTERNATIONAL4
TECOBIOSCIENCES4
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN4
THE UNIVERSITY OF SHEFFIELD4
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'4
UNIVERSITA DEGLI STUDI DI SIENA4
UNIVERSITA DEGLI STUDI DI TORINO4
UNIVERSITY OF BERGEN4
UNIVERSITY OF EASTERN FINLAND4
UNIVERSITY OF GLASGOW4
UNIVERSITY OF LEEDS4
UNIVERSITY OF NEWCASTLE UPON TYNE4
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE4
WAGENINGEN UNIVERSITY4
AUSTRIAN RESEARCH CENTERS SIEBERDORF3
BAYER3
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL3
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES3
CONCENTRIS RESEARCH MANAGEMENT3
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE3
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY3

Constancy:

Total number of partners: 1525
Partner loyalty:
Frequent Partner: (> 2 projects): 696
Rare Partner: 829
Frequent / Rare Partner Ratio: 0.84

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Implementation research on the tailored, multidisciplinary NCD prevention package FRESHAIR4LIFE: Targeting tobacco and air pollution exposure in mid- to late adolescents in disadvantaged populations FRESHAIR4LIFEcoordinator2.149.81413
2023-01-01Glycans as Master Switches of B Cell Activity in Autoimmunity GlycanSwitchcoordinator9.997.5003
2023-01-01GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION GlycanTriggerparticipant6.771.5719
2022-12-01GLYCOTwinning: Building Networks to Excel in Glycosciences GLYCOTwinningparticipant1.231.3754
2022-12-01Maximising Impact of Prescription Drugs in Rheumatoid Arthritis SQUEEZEparticipant8.602.31613
2022-11-01Identification and development of novel colorectal cancer biomarkers via state-of-the-art liquid biopsy approaches ColoMARKparticipant2.656.67816
2022-10-01Reversing vaccine hypo-responsiveness REVERSEcoordinator2.372.6811
2022-10-01DNA replication at the heart of cell fate decisions and cancer development RepliFateparticipant2.650.31321
2022-09-01Gene Therapy of Rare Diseases GetRadiparticipant2.785.81014
2022-06-01Improve Safety in Polymedication by Managing Drug-Drug-Gene Interactions SafePolyMedparticipant5.650.44313
2022-06-01Mechanisms at the interface of DNA damage repair and transcription STOP-FIX-GOcoordinator1.999.7641
2022-06-01Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection. ReCHISVaccoordinator234.5302
2022-05-01Adopting ISO 82304-2 and a trusted EU mHealth label for a single market that enables patients, citizens, health professionals, systems and authorities to benefit from a healthy supply of useful apps. Label2Enablecoordinator1.999.95714
2022-02-01Integrated Services for Infectious Disease Outbreak Research ISIDOReparticipant20.998.624154
2021-09-01Portable, accessible and sustainable magnetic resonance PASMARcoordinator2.493.7151
2021-09-01Human mini hearts: looking for culprits and victims in cardiac disease Mini-HEARTparticipant2.000.0002
2021-09-01Innovations to accelerate vaccine development and manufacture Inno4Vacparticipant18.600.00041
2021-06-01Psychiatric Ratings using Intermediate Stratified Markers 2 PRISM 2participant3.980.90618
2021-05-01A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE-ENTRANT TACHYCARDIA STOPSTORMparticipant7.161.43731
2021-05-01PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL TTV GUIDE TXparticipant6.099.83121
2021-04-01Coordinating Research and Evidence for Medical Devices CORE-MDparticipant2.360.97823
2021-04-01Exploitation of a low-field scanner for physiotherapy and rheumatology PR scannerparticipant100.0002
2021-03-01European Rare dIsease research Coordination and support Action ERICAcoordinator2.313.80927
2021-03-01Nanoparticle-Based Imaging and Therapy of Chronic Pain in the Dorsal Root Ganglia (DRG) PIANOparticipant4.093.42511
2021-03-01NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 A-TANGOparticipant5.999.99914
2021-03-01HealthyCloud – Health Research & Innovation Cloud HealthyCloudparticipant2.999.97526
2021-03-01APC/C substrates: how are they disengaged from their non-degraded binding partners? UbiBranchcoordinator187.5721
2021-02-01The dark side of the genome: systematically studying the biology of repressive elements—silencers—in the human genome Silencercoordinator1.750.0001
2021-02-01Embedding a comprehensive ethical dimension to organoïd-based research and resulting technologies HYBRIDAparticipant2.995.7858
2021-02-01European consortium for communicating gene- and cell-based therapy information. EuroGCTparticipant1.999.78447
2021-01-01Viruses and Epitranscriptomics: seeking novel targets for antiviral therapy EpiViralparticipant878.4464
2021-01-01Targeting auto-reactive B-cells by vaccination to cure human auto-immune disease Target to B-curecoordinator2.500.0001
2021-01-01Drug repurposing and discovery multidisciplinary training network DRUGtraincoordinator2.394.8178
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-10-01Immunological incompatibility as a basis for cancer curing and vaccination ULISESparticipant2.977.16011
2020-09-01Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM RadoNormparticipant18.000.00060
2020-09-01Biosafety assays for the diagnosis and prediction of drug-related complement pathology Biosafetyparticipant900.0006
2020-09-01Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling ACQUIREcoordinator150.0001
2020-08-01Indo-European Consortium for Next Generation Influenza Vaccine Innovation INCENTIVEparticipant9.974.29421
2020-06-01DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE TRANSVAC-DSparticipant1.879.21628
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00023
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05541
2020-05-01Staff Exchange for Novel applications in 19f magnetic resonance imaging SENATORparticipant1.541.00011
2020-04-01Swift COronavirus therapeutics REsponse SCOREcoordinator2.576.06310
2020-04-01Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine Prevent-nCoVparticipant2.728.3409
2020-04-01proactive monitoring of cancer as an alternative to surgery PRISAR2participant2.484.00025
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18643
2020-04-01Human Brain Project Specific Grant Agreement 3 HBP SGA3participant150.000.000162
2020-03-01Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe ISLETparticipant7.999.9998
2020-03-01Critical solutions for elderly well-being RISE-WELLcoordinator2.691.2797

overview shows latest 50 from 80 projects (2019-01-01 - 2024-12-31)
A full list of projects can be found here:

Alias institution names:

  • LEIDS UNIVERSITAIR MEDISCH CENTRUM